Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals

Toxicology and Applied Pharmacology

Volumn 155, Issue 2, 1999, Pages 150-160

  Vinggaard, Anne Marie ^a   Bonefeld Joergensen, Eva Cecilie ^b   Larsen, John Christian ^a  

^a DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ENVIRONMENTAL CHEMICAL; ESTROGEN RECEPTOR;

ARTICLE; ASSAY; CHEMICAL ANALYSIS; ENZYME ACTIVITY; ESTROGEN ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MALE GENITAL SYSTEM; MOUSE MAMMARY TUMOR ONCOVIRUS; RECEPTOR GENE; REPRODUCTIVE TOXICITY;

CRICETINAE; CRICETULUS GRISEUS; MAMMARY TUMOR ONCOVIRUS; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE;

EID: 0344507322     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8598     Document Type: Article

References (25)

1. Breinholt V., Larsen J. C. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol. 11:1998;622-629.
2. Brinkmann A. O., Faber P. W., van Rooij H. C. J., Kuiper G. G. J. M., Ris C., Klaassen P., van der Korput J. A. G. M., Voorhorst M. M., van Laar J. H., Mulder E., Trapman J. The human androgen receptor: Domain structure, genomic organization and regulation of expression. J. Steroid Biochem. 34:1989;307-310.
3. Cato A. C. B., Page M., Henderson D., Panta H. The hormone response elements of mouse mammary tumour virus DNA mediates progestin and androgen induction of transcription in the long term repeat region. EMBO J. 6:1987;363-368.
4. Colborn T., Dumanoski D., Myers J. P. Our Stolen Future. 1996;Penguin Books, New York.
5. Doesburg P., Kuil C. W., Berrevoets C. A., Steketee K., Faber P. W., Mulder E., Brinkmann A. O., Trapman J. Functionalin vivo. Biochemistry. 36:1997;1052-1064.
6. Foster P. M. D. Assessing the effects of chemicals on male reproduction: Lessons learned from di-n. CIIT Activities. 17:1997;1-8.
7. Freedman L. P. Anatomy of the steroid receptor zinc finger region. Endocrine Rev. 13:1992;129-145.
8. Gray L. E. Jr., Kelce W. R., Wiese T., Tyl R., Gaido K., Cook J., Klinefelter G., Desaulniers D., Wilson E., Zacharewski T., Waller C., Foster P., Laskey J., Reel J., Giesy J., Laws S., McLachlan J., Breslin W., Cooper R., Di Giulio R., Johnson R., Purdy R., Mihaich E., Safe S., Sonnenschein C., Welshons W., Miller R., McMaster S., Colborn T. Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:1997;719-750.
9. Hosokawa S., Murakami M., Ineyama M., Yamada T., Yoshitake A., Yamada H., Miyamoto J. The affinity of procymidone to androgen receptor in rats and mice. J. Toxicol. Sci. 18:1993;111-124.
10. Joergensen E. C. B., Autrup H. Effect of a negative regulatory element (NRE) on the human CYP1A1 gene expression in breast carcinoma MCF-7 and hepatoma HepG2 cells. FEBS Lett. 365:1995;101-107.
11. Joergensen E. C. B., Autrup H. Autoregulation of the human CYP1A1 gene promoter activity in HepG2 and MCF-7 cells. Carcinogenesis. 17:1996;435-441.
12. Joergensen E. C. B., Autrup H., Hansen J. C. Effect of toxaphene on estrogen receptor functions in human breast cancer cells. Carcinogenesis. 18:1997;1651-1654.
13. Kelce W. R., Stone C. R., Laws S. C., Gray L. E., Kemppainen J. A., Wilson E. M. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature. 375:1995;581-585.
14. Kelce W. R., Wilson E. M. Environmental antiandrogens: Developmental effects, molecular mechanisms, and clinical implications. J. Mol. Med. 75:1997;198-207.
15. Kuil C. W., Mulder E. Mechanism of antiandrogen action: Conformational changes of the receptor. Mol. Cell. Endocrinol. 102:1994;R1-R5.
16. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell. 55:1988;145-156.
17. Nakayama G. R., Caton M. C., Nova M. P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viabilityin vitro. J. Immunol. Methods. 204:1997;205-208.
18. Ringold G. M., Dobson D. E., Grove J. R., Hall C. V., Lee F., Vannice J. L. Glucocorticoid regulation of gene expression: Mouse mammary tumour virus as a model system. Recent Prog. Horm. Res. 39:1983;387-421.
19. Ruiter de P. E., Teuwen R., Trapman J., Dijkema R., Brinkmann A. O. Synergism between androgens and protein kinase-C on androgen-regulated gene expression. Mol. Cell. Endocrinol. 110:1995;R1-R6.
20. Sharpe R. M., Skakkebaek N. F. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet. 341:1993;1392-1395.
21. Shen P., Xie Z.-J., Li H., Sánchez E. R. Glucocorticoid receptor conversion to high affinity nuclear binding and transcription enhancement activity in chinese hamster ovary cells subjected to heat and chemical stress. J. Steroid Biochem. Molec. Biol. 47:1993;55-64.
22. Toppari J., Larsen J. C., Christiansen P., Giwercman A., Grandjean P., Guillette L. J. Jr., Jegou B., Jensen T. K., Jouannet P., Keiding N., Leffers H., McLachlan J. A., Meyer O., Muller J., Rajpert De Meyts E., Scheike T., Sharpe R., Sumpter J., Skakkebaek N. F. Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. 104:1996;741-803.
23. Wilson E. M., French F. S. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J. Biol. Chem. 251:1976;5620-5629.
24. Wong C., Kelce W. R., Sar M., Wilson E. M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270:1995;19998-20003.
25. Yeh S., Miyamoto H., Chang C. Hydroxyflutamide may not always be a pure antiandrogen. Lancet. 349:1997;852-853.